Dr. Khurana's clinical and research interests include comprehensive multidisciplinary management of severe asthma. She believes in a patient-centered team-based approach to management of this complex condition. She has expertise in application of novel therapies for severe asthma including new monoclonal antibodies and Bronchial Thermoplasty (a non-pharmacologic endoscopic therapy for severe asthma). She is the site principal investigator in multicenter clinical trials evaluating new treatments in asthma. She is a co-investigator in the SOAR (Study Of Asthma in Rochester) asthma registry focused on characterization of asthma using non-invasive biomarkers.
